Theravance Biopharma Inc (TBPH)
9.585
-0.02
(-0.26%)
USD |
NASDAQ |
Nov 22, 14:58
Theravance Biopharma Shareholders Equity (Quarterly): 185.65M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 185.65M |
| June 30, 2024 | 193.69M |
| March 31, 2024 | 204.87M |
| December 31, 2023 | 213.00M |
| September 30, 2023 | 246.13M |
| June 30, 2023 | 280.16M |
| March 31, 2023 | 370.56M |
| December 31, 2022 | 441.80M |
| September 30, 2022 | 480.58M |
| June 30, 2022 | -349.81M |
| March 31, 2022 | -351.45M |
| December 31, 2021 | -338.57M |
| September 30, 2021 | -323.59M |
| June 30, 2021 | -300.37M |
| March 31, 2021 | -373.22M |
| December 31, 2020 | -303.75M |
| September 30, 2020 | -261.54M |
| June 30, 2020 | -202.34M |
| March 31, 2020 | -157.94M |
| December 31, 2019 | -223.84M |
| September 30, 2019 | -182.80M |
| June 30, 2019 | -137.22M |
| Date | Value |
|---|---|
| March 31, 2019 | -113.25M |
| December 31, 2018 | -51.59M |
| September 30, 2018 | -13.44M |
| June 30, 2018 | 34.39M |
| March 31, 2018 | 63.41M |
| December 31, 2017 | 115.18M |
| September 30, 2017 | 184.12M |
| June 30, 2017 | 241.13M |
| March 31, 2017 | 293.95M |
| December 31, 2016 | 350.23M |
| September 30, 2016 | 297.87M |
| June 30, 2016 | 321.58M |
| March 31, 2016 | 238.54M |
| December 31, 2015 | 243.06M |
| September 30, 2015 | 222.54M |
| June 30, 2015 | 257.67M |
| March 31, 2015 | 289.12M |
| December 31, 2014 | 289.79M |
| September 30, 2014 | 339.82M |
| June 30, 2014 | 384.76M |
| March 31, 2014 | -17.92M |
| December 31, 2013 | -17.04M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-373.22M
Minimum
Mar 2021
480.58M
Maximum
Sep 2022
-28.50M
Average
-180.14M
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 638.84M |
| Madrigal Pharmaceuticals Inc | 777.16M |
| Ionis Pharmaceuticals Inc | 662.47M |
| Jazz Pharmaceuticals PLC | 4.171B |
| NovaBay Pharmaceuticals Inc | 1.072M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 356.10M |
| Total Liabilities (Quarterly) | 170.45M |
| Current Ratio | 4.970 |